Where can researchers source third-party tested Melanotan II?

Midwest Peptide supplies research-grade Melanotan II with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Memorial Day: 15% off code MEMDAY15Memorial Day Sale — 15% off site-wide with code MEMDAY15

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

Melanotan II Pigmentation Research | Midwest Peptide

MC4R Appetite Research: Melanotan II Central EffectsPrev|Melanotan II Receptor Research: MC1R and MC4R Binding StudiesNext

Melanotan II Pigmentation Research: Animal Model Studies

Q: Is Melanotan II approved for human use?

No. Melanotan II is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Melanotan II · Published April 9, 2026 · Updated May 18, 2026 · 8 min read

Quick Answer

Melanotan II pigmentation research examines melanogenic enzyme expression, melanin content, eumelanin shifts, and animal pigmentation phenotype in rodent models of broad melanocortin receptor activation. Studies measure tyrosinase activity, MITF expression, and quantitative pigmentation biomarkers across standardized research protocols. For research use only, not for human consumption.

Melanotan II Pigmentation Research: Animal Model Studies

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

Pigmentation Research as a Research Endpoint
Animal Models of Pigmentation Research
Melanogenic Enzyme Effects
Melanin Content and Pigmentation Phenotype
Comparison With Selective MC1R Agonists
UV Protection and Photoprotection Research
Open Research Questions
Conclusion
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

Melanotan II pigmentation research provides one of the most active areas of preclinical literature on melanocortin receptor-mediated melanogenesis. As a non-selective melanocortin agonist with measurable activity at MC1R, Melanotan II has been characterized in multiple animal research models for its effects on melanin pigment production and on the broader pigmentation phenotype. As the pigmentation research component of the Melanotan II research cluster, this article reviews the published animal model literature on Melanotan II pigmentation effects.

Frequently Asked Questions

What is Melanotan II in research contexts?

Melanotan II is a synthetic cyclic heptapeptide non-selective melanocortin receptor agonist that binds MC1R, MC3R, MC4R, and MC5R. It is studied in preclinical research for pigmentation, central appetite signaling, and melanocortin pharmacology.

How does Melanotan II drive pigmentation in research?

Melanotan II activates MC1R on melanocytes alongside other melanocortin receptors. The MC1R component drives eumelanin synthesis through tyrosinase upregulation, producing pigmentation effects similar to but accompanied by the central effects of broader melanocortin engagement.

How does Melanotan II pigmentation differ from Melanotan I?

Both peptides drive pigmentation through MC1R, but Melanotan II's broader melanocortin receptor engagement adds central appetite and sexual behavior effects, distinguishing the integrated phenotype from MC1R-selective Melanotan I in rodent and clinical research.

Is Melanotan II approved for human use?

Glossary

Key terms used in this article.

MC1R: Melanocortin 1 receptor, the GPCR on melanocytes mediating pigmentation effects of melanocortin agonists.
MC4R: Melanocortin 4 receptor, primarily expressed in the hypothalamus and central nervous system, regulating appetite and sexual behavior.
MC5R: Melanocortin 5 receptor, broadly distributed and implicated in exocrine function and lipolysis.
Cyclic Peptide: A peptide whose backbone or side chains are joined into a ring, conferring increased stability and receptor selectivity.
Bremelanotide: A cyclic melanocortin agonist analog of Melanotan II with reduced MC1R activity, studied for central effects.
Eumelanin: The dark brown to black melanin pigment that provides photoprotective absorbance of UV radiation.
Tyrosinase: The rate-limiting copper-dependent enzyme catalyzing the first two steps of melanin biosynthesis from tyrosine.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. Melanotan II is intended exclusively for in vitro and preclinical research. It is not approved for human use, is not a drug, supplement, or cosmetic product, and should never be administered to humans or to animals outside of an authorized research protocol.

Pigmentation Research as a Research Endpoint

Pigmentation in research animals is regulated by complex genetic, hormonal, and environmental factors, with the melanocortin receptor system being one of the most important regulatory pathways. Pigmentation phenotype in research animals is typically characterized through measurements of skin and hair color, melanin content in tissue samples, expression of melanogenic enzymes in melanocytes, and various other endpoints related to melanocyte function.

The melanocortin pathway converges on melanocytes, the specialized cells responsible for melanin production. Melanocytes express MC1R prominently and respond to alpha-MSH and to synthetic melanocortin agonists like Melanotan II by activating the canonical melanogenesis cascade. This cascade involves cyclic AMP, CREB, MITF, and the downstream melanogenic enzymes (tyrosinase, TRP-1, TRP-2) that convert tyrosine into eumelanin and pheomelanin pigments.

Research using Melanotan II in pigmentation studies has used these endpoints to characterize how non-selective melanocortin activation affects pigmentation in animal models. The published findings consistently support increased pigmentation effects following Melanotan II administration, with the magnitude depending on the specific research animal model and experimental conditions.

Animal Models of Pigmentation Research

Several animal model systems are used in pigmentation research with Melanotan II, each offering specific advantages for different experimental questions.

Mouse models are widely used in pigmentation research because of the genetic tractability of the species and the availability of multiple strains with different pigmentation phenotypes. Wild-type strains, agouti mice, recessive yellow mice, and various other research strains provide a range of baseline pigmentation backgrounds against which Melanotan II effects can be measured. The mouse models are particularly useful for genetic studies of pigmentation mechanisms.

Other rodent models including rats and hamsters have also been used in pigmentation research with Melanotan II, providing complementary data across multiple research animal species. The cross-species findings support the conclusion that Melanotan II pigmentation effects are conserved across mammalian research animals.

In vitro melanocyte cultures provide a complementary approach to whole-animal pigmentation studies. Cultured melanocytes from various species can be used to characterize the immediate cellular effects of Melanotan II on melanogenesis, with measurements of melanogenic enzyme expression, melanin content, and cellular morphology providing direct readouts of receptor activation and downstream signaling.

The combination of in vitro cell culture studies and whole-animal model studies provides a comprehensive picture of how Melanotan II affects pigmentation in research models at multiple levels of analysis.

Melanogenic Enzyme Effects

The melanogenic enzymes tyrosinase, TRP-1, and TRP-2 are the central effectors of melanin synthesis in melanocytes. Their expression and activity are regulated by MC1R signaling through the MITF transcription factor, and Melanotan II has been characterized for its effects on these enzymes in research models.

Studies using quantitative PCR for mRNA expression, Western blot for protein levels, and enzymatic activity assays have characterized increases in melanogenic enzyme expression following Melanotan II treatment. Tyrosinase, as the rate-limiting enzyme in the melanogenesis pathway, is the most extensively studied of these enzymes and shows consistent increases in expression and activity following Melanotan II administration in research models.

The increases in melanogenic enzyme expression following Melanotan II treatment are dose dependent and time dependent, with detectable effects within hours of administration and maximal effects developing over days of sustained signaling. This time course reflects the transcriptional regulation mechanism through which MC1R signaling affects gene expression in melanocytes.

For more on the receptor biology that initiates this cascade, see our companion article on Melanotan II receptor research and MC1R/MC4R binding.

Melanin Content and Pigmentation Phenotype

Beyond enzyme expression measurements, melanin content in research animal tissues provides a direct functional readout of pigmentation effects. Melanotan II research using melanin content measurements has consistently shown increases in melanin content in skin and hair following peptide administration in research animals.

The increases in melanin content develop over time as the cellular machinery for melanin production is activated and as melanin accumulates in melanosomes. The functional outcome is increased pigmentation in research animals exposed to Melanotan II in standardized protocols.

The specific type of melanin produced (eumelanin versus pheomelanin) is also affected by MC1R activation, with the published findings supporting a shift toward eumelanin production following Melanotan II treatment. Eumelanin is the dark pigment that provides UV-protective effects in research models, and the shift toward eumelanin production has been one of the more discussed features of MC1R-mediated melanogenesis.

In whole-animal pigmentation studies, the molecular changes in enzyme expression and melanin content translate to visible changes in coat color and skin pigmentation in research animals. The magnitude of the visible changes depends on the baseline pigmentation phenotype, the duration of administration, and the experimental conditions.

Comparison With Selective MC1R Agonists

The pigmentation effects of non-selective Melanotan II can be compared with those of more selective MC1R agonists like Melanotan I in research models. The comparison provides useful information about how different selectivity profiles affect pigmentation outcomes and helps researchers understand the relative contributions of MC1R versus other melanocortin receptors to the observed effects.

The general finding is that both selective and non-selective melanocortin agonists produce pigmentation effects through MC1R activation, with the magnitudes being broadly comparable when accounting for differences in receptor binding affinity. The non-selective profile of Melanotan II adds effects from other melanocortin receptors (MC3R, MC4R, MC5R) that do not contribute directly to pigmentation but may modulate other aspects of the integrated biological response.

For more on the comparison, see our companion article on Melanotan I vs Melanotan II receptor selectivity in research in the Melanotan I research cluster.

UV Protection and Photoprotection Research

The functional significance of melanogenesis in research models includes the role of melanin in protecting cells from UV-induced damage. Eumelanin provides photoprotective effects in research models by absorbing UV photons and dissipating their energy as heat, reducing the amount of UV energy that can damage cellular DNA and other macromolecules.

Melanotan II research has examined whether the increased pigmentation produced by the peptide translates to functional photoprotective effects in research models. The published findings generally support such effects, consistent with the increased eumelanin content observed following peptide administration. These studies use various endpoints including skin damage measurements, DNA damage assays, and cellular survival following UV challenge.

The UV-protective function of melanocortin-induced pigmentation is one of the original research interests that motivated the development of Melanotan II and related peptides. The recognition that activation of melanogenesis through MC1R signaling could provide UV protection through pigmentation rather than through UV exposure was one of the foundational concepts in the original University of Arizona research program.

Open Research Questions

Several open research questions remain in the Melanotan II pigmentation literature. These include how the magnitude of pigmentation effects varies across different research animal models with different baseline pigmentation, how the kinetics of melanogenic enzyme expression changes relate to functional pigmentation outcomes, and how Melanotan II pigmentation effects compare quantitatively with those of more selective MC1R agonists in standardized research protocols. Each of these is a legitimate research opportunity for investigators studying melanocyte biology.

Conclusion

Melanotan II pigmentation research provides one of the most active areas of preclinical literature on melanocortin receptor-mediated melanogenesis. The convergent findings on melanogenic enzyme expression, melanin content increases, eumelanin shifts, and whole-animal pigmentation phenotype changes support the use of Melanotan II as a research tool for studies of melanocortin-mediated pigmentation. For investigators using MT-2 10mg as a research tool, the pigmentation literature provides essential context for experimental design.

For more on the full Melanotan II research cluster, see the pillar overview article and the supporting articles on each major topic.

Melanotan II is supplied by Midwest Peptide for research use only and is not intended for human administration.

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

MT-1 10mg, 99%+ purity, COA included
MT-2 10mg, 99%+ purity, COA included
GHK-Cu 50mg, 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

Melanotan II Pigmentation Research: Animal Model Studies

Frequently Asked Questions

What is Melanotan II in research contexts?

How does Melanotan II drive pigmentation in research?

How does Melanotan II pigmentation differ from Melanotan I?

Is Melanotan II approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

Pigmentation Research as a Research Endpoint

Animal Models of Pigmentation Research

Melanogenic Enzyme Effects

Melanin Content and Pigmentation Phenotype

Comparison With Selective MC1R Agonists

UV Protection and Photoprotection Research

Open Research Questions

Conclusion

Ready to Start Your Research?

Where can researchers source third-party tested Melanotan II?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?

Age Verification

Melanotan II Pigmentation Research: Animal Model Studies

Frequently Asked Questions

What is Melanotan II in research contexts?

How does Melanotan II drive pigmentation in research?

How does Melanotan II pigmentation differ from Melanotan I?

Is Melanotan II approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

Pigmentation Research as a Research Endpoint

Animal Models of Pigmentation Research

Melanogenic Enzyme Effects

Melanin Content and Pigmentation Phenotype

Comparison With Selective MC1R Agonists

UV Protection and Photoprotection Research

Open Research Questions

Conclusion

Related Research Articles

Explore Related Products

Ready to Start Your Research?

Where can researchers source third-party tested Melanotan II?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?